Barnes Dennig Private Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$166K Sell
1,060
-26
-2% -$3.9K 0.13% 99
2026
Q1
$166K Hold
1,086
0.16% 86
2025
Q4
$150K Buy
+1,086
New +$142K 0.15% 85

Other funds holding NVS

Barnes Dennig Private Wealth Management's NVS Position: Q2 2026 in Review

Barnes Dennig Private Wealth Management reduced its Novartis (NVS) stake by 2.4% in Q2 2026, selling an estimated $3.9K and leaving 1,060 shares worth $166K. The position accounts for 0.13% of the portfolio, ranked #99.

Barnes Dennig Private Wealth Management first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Barnes Dennig Private Wealth Management held 1,060 shares of Novartis worth $166K as of Q2 2026.
  • Barnes Dennig Private Wealth Management sold 26 Novartis shares in Q2 2026, an estimated $3.9K.
  • Novartis made up 0.13% of Barnes Dennig Private Wealth Management's portfolio in Q2 2026, its #99 holding.
  • Barnes Dennig Private Wealth Management first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Barnes Dennig Private Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.